Mitochondrial dysfunction and immune activation are detectable in early Alzheimer’s disease blood

Manuscript Number: 

11-1592R3

Author(s): 
Giovanni Coppola, Richard Dobson, Simon Furney, Daniel H. Geschwind, Angela Hodges, Zina Ibrahim, Iwona Kloszewska, Anbarasu Lourdusamy, Simon Lovestone, Katie Lunnon, Patrizia Mecocci, Stephen Newhouse, Petroula Proitsi, Muzamil Saleem, Martina Sattlecker, Andrew Simmons, Hilkka Soininen, Magda Tsolaki, Bruno Vellas

Disclosures

Giovanni Coppola

  • Nothing to Disclose

Richard Dobson

  • Nothing to Disclose

Simon Furney

  • Nothing to Disclose

Daniel H. Geschwind

  • Nothing to Disclose

Angela Hodges

  • Nothing to Disclose

Zina Ibrahim

  • Nothing to Disclose

Iwona Kloszewska

  • Nothing to Disclose

Anbarasu Lourdusamy

  • Nothing to Disclose

Simon Lovestone

  • Consulting Fees:
    Consultancy to Astra Zeneca, GEHC, Noscira, Pfizer
    Lecture Fees:
    Speaker fees for lectures to Lundbeck Neuroscience Foundation
    Patents/Royalties
    Patents held by KCL for biomarkers for AD on which I am named as an inventor
    Grants
    • Agency: 
      Astra Zeneca
      Dates: 
      2012-16
    • Agency: 
      J&J
      Dates: 
      2011-13

Katie Lunnon

  • Nothing to Disclose

Patrizia Mecocci

  • Nothing to Disclose

Stephen Newhouse

  • Nothing to Disclose

Petroula Proitsi

  • Nothing to Disclose

Muzamil Saleem

  • Nothing to Disclose

Martina Sattlecker

  • Nothing to Disclose

Andrew Simmons

  • Nothing to Disclose

Hilkka Soininen

  • Consulting Fees:
    ACImmune consulting.

Magda Tsolaki

  • Consulting Fees:
    1. Novartis
    Lecture Fees:
    1.Novartis 2.Pfizer

Bruno Vellas

  • Nothing to Disclose